Sertraline reduced the severity of patients' depressive symptoms in major depressive disorder
نویسندگان
چکیده
منابع مشابه
profile of major depressive disorder symptoms among patients in tehran
objectives: culture may place a differential emphasis on particular emotions. the aim of this study is to find the most frequent symptoms in patients with major depressive disorder in tehran. method: 509 patients were recruited from 5 treatment settings. the sample was used from the project of assessing psychometric properties of cidi in the iranian population. the patients were evaluated by co...
متن کاملIdentifying Early Maladaptive Schema of Patients with Major Depressive Disorder
Cognitive models of depression propose that negative schemas and Early Maladaptive Schema contribute to depressive symptoms. The purpose of this study is to identify the early maladaptive Schema of patients with depression disorder. The method of study is descriptive. Research statistics involves all patients with depression disorder who have come to the c...
متن کاملSheehan’s Syndrome Presenting as Major Depressive Disorder
Sheehan’s syndrome or Simmond’s disease is a rare endocrine disorder seen in clinical practice. The clinical spectrum is diverse and a high index of suspicion together with a good clinical acumen and proper diagnostic approach helps in early diagnosis and prompt treatment of this endocrinopathy. Sheehan’s syndrome presenting as a major depressive disorder finds less mention in the literature.Th...
متن کاملSertraline improves symptoms in children and adolescents with major depressive disorder.
Patients: 376 children and adolescents aged 6 to 17 years with a current episode of MDD (DSM-IV criteria) lasting at least 6 weeks, and scoring at least 45 on the Children’s Depression Rating Scale-Revised (CDRS-R) and at least 4 on the Clinical Global Impression Scale of Severity of Illness (CGI-S) during 3 visits within a 2 week screening period. Exclusions: attentiondeficit/hyperactivity dis...
متن کاملSertraline: a review of its use in the management of major depressive disorder in elderly patients.
UNLABELLED Sertraline is a selective serotonin reuptake inhibitor (SSRI) with well established antidepressant and anxiolytic activity. Results from several well designed trials show that sertraline (50 to 200 mg/day) is effective in the treatment of major depressive disorder in elderly patients (> or =60 years of age). Primary endpoints in most studies included the Hamilton Depression Rating Sc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Evidence-Based Medicine
سال: 2004
ISSN: 1356-5524
DOI: 10.1136/ebm.9.2.46